Renapar
Renapar is an FDA drug label for the active ingredient PAREIRA BRAVA, PETROSELINUM SATIVUM, SARSAPARILLA (SMILAX REGELII), KIDNEY (SUIS), BRYONIA (ALBA), MERCURIUS CORROSIVUS, RUBIA TINCTORUM, SOLIDAGO VIRGAUREA, TRITICUM REPENS manufactured by Energique, Inc. administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231201.
Generic: PAREIRA BRAVA, PETROSELINUM SATIVUM, SARSAPARILLA (SMILAX REGELII), KIDNEY (SUIS), BRYONIA (ALBA), MERCURIUS CORROSIVUS, RUBIA TINCTORUM, SOLIDAGO VIRGAUREA, TRITICUM REPENS
Manufacturer: Energique, Inc.
Product Type: HUMAN OTC DRUG
Route: ORAL
Dosage Form:
NDC: 44911-0641
Application:
Effective: 20231201
Active Ingredients: ACTIVE INGREDIENTS: (in each drop): 14.26% of Bryonia (Alba) 12X, Kidney (Suis) 6X, Mercurius Corrosivus 12X, Pareira Brava 8X, Rubia Tinctorum 12X, Solidago Virgaurea 12X, Triticum Repens 12X; 0.10% of Petroselinum Sativum 3X, Sarsaparilla (Smilax Regelii) 3X.
Indications & Usage
INDICATIONS: May temporarily relieve sudden desire to urinate, urination difficult and scanty, and frequent urging on urination.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Dosage & Administration
DIRECTIONS: Adults and children 5 to 10 drops orally, 3 times daily or as otherwise directed by a health care professional. If symptoms persist for more than 7 days, consult your health care professional. Consult a physician for use in children under 12 years of age.
Contraindications
Not available.
Warnings
WARNINGS: If pregnant or breastfeeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in a cool, dry place.
Adverse Reactions
Not available.
More from same ingredient
No related products.